A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
BeOne Medicines
BeOne Medicines
BeOne Medicines
Pfizer
The Methodist Hospital Research Institute
Martini-Klinik am UKE GmbH
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Institut Curie
M.D. Anderson Cancer Center
UNICANCER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
NYU Langone Health
Azienda Ospedaliero-Universitaria di Modena
Regeneron Pharmaceuticals
BPGbio
UNICANCER
Institut Paoli-Calmettes
Capital Medical University
Jiangsu Cancer Institute & Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Chinese PLA General Hospital
Fudan University
State Scientific Centre of Coloproctology, Russian Federation
ChineseAMS
Dana-Farber Cancer Institute
Xi'an Jiaotong University
UNICANCER
Abramson Cancer Center at Penn Medicine
University of Florida
Gustave Roussy, Cancer Campus, Grand Paris
Federation of Breast Diseases Societies
University of Leicester
Yonsei University
Institut Cancerologie de l'Ouest
West China Hospital
Chinese University of Hong Kong
Georgetown University
Vrinnevi Hospital
Cell Genesys
Cell Genesys
Light Sciences LLC
Light Sciences LLC
FeRx